Pharmaceutical groups are increasingly relying on real-world data (RWD) to accelerate drug development and optimize clinical trial design. Despite this, accessing, analyzing, and understanding complex RWD often be https://umairjsbg571933.blog-gold.com/47785702/datma-s-federated-biomarker-explorer-free-effortless-real-world-data-assessment-for-pharma-teams